Skip to content

Drug interactions

Ipratropium-salbutamol + Panobinostat

Severity: Major

Ipratropium-salbutamol and Panobinostat: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Panobinostat carries a labeled risk of QT prolongation and severe arrhythmia. Salbutamol can add to this risk through tachycardia and lowering of potassium, particularly at high doses.

What this interaction means in plain words

Ipratropium-salbutamol and Panobinostat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ipratropium-salbutamol belongs to Respiratory; Panobinostat belongs to Oncology.

Evidence level: Low

Why it happens

Additive QT prolongation, with beta-agonist-induced hypokalemia as a risk factor.

What to do

Monitor ECG and keep potassium and magnesium within normal range during panobinostat treatment. Minimize salbutamol use and avoid high doses where possible.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ipratropium-salbutamol and Panobinostat, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ipratropium-salbutamol with Panobinostat?

MediHelp rates the interaction as major. Ipratropium-salbutamol and Panobinostat can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Panobinostat carries a labeled risk of QT prolongation and severe arrhythmia. Salbutamol can add to this risk through tachycardia and lowering of potassium, particularly at high doses.

How serious is the interaction between Ipratropium-salbutamol and Panobinostat?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor ECG and keep potassium and magnesium within normal range during panobinostat treatment. Minimize salbutamol use and avoid high doses where possible.

What other medicines interact with Ipratropium-salbutamol?

MediHelp also lists interactions of Ipratropium-salbutamol with, for example, Amisulpride, Arsenic trioxide, Carvedilol. The full list is on the Ipratropium-salbutamol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in